OSCR

Integrative genome-scale metabolic model of GABAergic neurons reveals metabolic signatures across the mild cognitive impairment - Alzheimer disease continuum.

Overview

Authors: Andrea Angarita-Rodríguez1,2, Johan H Largo-González1,2, Julián Pérez-Mejía1, Daniel Balcazar1, Viviana Vargas-López1, Jason A Papin3,4,5, Andrés Pinzón2, Janneth González1
  1. Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá, Colombia
  2. Laboratorio de Bioinformática y Biología de Sistemas, Universidad Nacional de Colombia Bogotá, Bogotá, Colombia
  3. Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States
  4. Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, United States
  5. Department of Biochemistry & Molecular Genetics, University of Virginia, Charlottesville, VA, United States
Journal: Frontiers in systems biology, volume 6, article 1897648
Dates: received 2 June 2026; accepted 10 August 2026; published online 3 September 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fsysb.2026.1897648 · PMID 42755753 · PMCID PMC13581822 · OpenAlex W7207744029
Open access: gold, a free copy (OpenAlex)
Categories: genetics / omics (modality), Alzheimer's / dementia (population)
Methods: Statistics, Preprocessing, Connectivity
Keywords: Alzheimer’s disease, GABAergic neurons, genome-scale metabolic models (GEMs), metabolic flexibility, metabolic reprogramming, mild cognitive impairment (MCI), transcriptomic deconvolution
Topic: Metabolomics and Mass Spectrometry Studies (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 73 references in the paper

Abstract

Introduction: Mild cognitive impairment (MCI) represents a prodromal stage of Alzheimer’s disease (AD), but the metabolic mechanisms underlying early neuronal dysfunction remain incompletely understood. GABAergic neurons, which maintain excitatory–inhibitory balance and network stability, exhibit early vulnerability during neurodegeneration, although the metabolic alterations associated with their dysfunction remain poorly characterized.

Methods: We developed a context-specific genome-scale metabolic model (GEM) of human GABAergic neurons across the MCI–AD continuum using deconvolved hippocampal transcriptomic data. By integrating transcriptomic deconvolution with constraint-based modeling, including flux balance analysis (FBA) and flux variability analysis (FVA), we inferred disease-stage-associated metabolic alterations under Control, early MCI (E-MCI), advanced MCI (A-MCI), and AD conditions.

Results: Our analyses suggest progressive remodeling of energy metabolism, the glutamate–glutamine–GABA cycle, redox homeostasis, lipid metabolism, and neuron–astrocyte metabolic interactions. FVA identified reaction-specific changes in feasible flux ranges, indicating remodeling of the feasible metabolic solution space rather than a uniform contraction across pathways. These predicted metabolic alterations were accompanied by transcriptional changes in GABAergic markers and showed qualitative agreement with independent metabolomic observations, supporting their biological plausibility.

Discussion: Overall, this work provides a systems-level computational framework linking transcriptomic alterations with predicted metabolic remodeling in GABAergic neurons and generates experimentally testable hypotheses regarding metabolic dysfunction during progression from MCI to AD.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 8 authors, 7 keywords, 72 references.

Cite

This paper

Angarita-Rodríguez, A., Largo-González, J. H., Pérez-Mejía, J., Balcazar, D., Vargas-López, V., Papin, J. A., Pinzón, A., & González, J. (2026). Integrative genome-scale metabolic model of GABAergic neurons reveals metabolic signatures across the mild cognitive impairment - Alzheimer disease continuum. Frontiers in systems biology, 6, 1897648. https://doi.org/10.3389/fsysb.2026.1897648

BibTeX

@article{angaritarodriguez2026integrative,
author = {Angarita-Rodríguez, Andrea and Largo-González, Johan H and Pérez-Mejía, Julián and Balcazar, Daniel and Vargas-López, Viviana and Papin, Jason A and Pinzón, Andrés and González, Janneth},
title = {{Integrative genome-scale metabolic model of GABAergic neurons reveals metabolic signatures across the mild cognitive impairment - Alzheimer disease continuum}},
journal = {Frontiers in systems biology},
year = {2026},
month = sep,
volume = {6},
pages = {1897648},
publisher = {Frontiers Media},
issn = {2674-0702},
doi = {10.3389/fsysb.2026.1897648},
url = {https://doi.org/10.3389/fsysb.2026.1897648},
pmid = {42755753},
pmcid = {PMC13581822}
}

RIS

TY - JOUR
AU - Angarita-Rodríguez, Andrea
AU - Largo-González, Johan H
AU - Pérez-Mejía, Julián
AU - Balcazar, Daniel
AU - Vargas-López, Viviana
AU - Papin, Jason A
AU - Pinzón, Andrés
AU - González, Janneth
TI - Integrative genome-scale metabolic model of GABAergic neurons reveals metabolic signatures across the mild cognitive impairment - Alzheimer disease continuum
T2 - Frontiers in systems biology
J2 - Front Syst Biol
PY - 2026
DA - 2026/09/03
VL - 6
SP - 1897648
SN - 2674-0702
PB - Frontiers Media
DO - 10.3389/fsysb.2026.1897648
UR - https://doi.org/10.3389/fsysb.2026.1897648
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fsysb.2026.1897648",
"type": "article-journal",
"title": "Integrative genome-scale metabolic model of GABAergic neurons reveals metabolic signatures across the mild cognitive impairment - Alzheimer disease continuum",
"container-title": "Frontiers in systems biology",
"author": [
{
"family": "Angarita-Rodríguez",
"given": "Andrea"
},
{
"family": "Largo-González",
"given": "Johan H"
},
{
"family": "Pérez-Mejía",
"given": "Julián"
},
{
"family": "Balcazar",
"given": "Daniel"
},
{
"family": "Vargas-López",
"given": "Viviana"
},
{
"family": "Papin",
"given": "Jason A"
},
{
"family": "Pinzón",
"given": "Andrés"
},
{
"family": "González",
"given": "Janneth"
}
],
"container-title-short": "Front Syst Biol",
"volume": "6",
"page": "1897648",
"DOI": "10.3389/fsysb.2026.1897648",
"PMID": "42755753",
"PMCID": "PMC13581822",
"ISSN": "2674-0702",
"publisher": "Frontiers Media",
"URL": "https://doi.org/10.3389/fsysb.2026.1897648",
"language": "en",
"issued": {
"date-parts": [
[
2026,
9,
3
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fbinf.2026.1816121 [code]
Transcriptome-informed metabolic modeling reveals astrocyte-specific vulnerabilities in mild cognitive impairment and Alzheimer's disease progression.
Journal: Frontiers in bioinformatics
In common: Alzheimer's / dementia, genetics / omics, 10 references
[2] doi:10.3389/fbinf.2026.1858866 [code]
Comparative evaluation of reference-free transcriptomic deconvolution highlights the importance of biological validation in astrocytes across Alzheimer's disease.
Journal: Frontiers in bioinformatics
In common: Alzheimer's / dementia, genetics / omics, 5 references
[3] doi:10.3390/biomedicines11020583
Neuroinflammation, Energy and Sphingolipid Metabolism Biomarkers Are Revealed by Metabolic Modeling of Autistic Brains.
Journal: Biomedicines
In common: 5 references
[4] doi:10.1016/j.isci.2026.115638 [code]
Genome-scale metabolic modeling uncovers cell-type specific signatures associated with APOE variants.
Journal: iScience
In common: Alzheimer's / dementia, genetics / omics, 4 references
[5] doi:10.1093/bib/bbae199 [code]
Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas.
Journal: Briefings in bioinformatics
In common: 4 references
[6] doi:10.1038/s42003-023-05548-w [code]
Omics data integration suggests a potential idiopathic Parkinson's disease signature.
Journal: Communications biology
In common: 4 references
[7] doi:10.3390/cells13010067
CREB1 Facilitates GABAergic Neural Differentiation of Human Mesenchymal Stem Cells through BRN2 for Pain Alleviation and Locomotion Recovery after Spinal Cord Injury.
Journal: Cells
In common: NCBI GEO GSE115565
[8] doi:10.3390/metabo15080499 [code]
Investigating Lipid and Energy Dyshomeostasis Induced by Per- and Polyfluoroalkyl Substances (PFAS) Congeners in Mouse Model Using Systems Biology Approaches.
Journal: Metabolites
In common: genetics / omics, 3 references
[9] doi:10.1038/s42256-022-00519-y [code]
Reconstructing Kinetic Models for Dynamical Studies of Metabolism using Generative Adversarial Networks.
Journal: Nature machine intelligence
In common: 3 references
[10] doi:10.1038/s41467-022-35017-7 [code]
Genetically personalised organ-specific metabolic models in health and disease.
Journal: Nature communications
In common: genetics / omics, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.